Opendata, web and dolomites

DosiKit TERMINATED

DosiKit, a first portable field medical device for fast triage of people after external irradiation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DosiKit project word cloud

Explore the words cloud of the DosiKit project. It provides you a very rough idea of what is the project "DosiKit" about.

hospitals    germany    army    survey    body    expose    singapore    energy    risk    initiated    irradiated    loi    2022    tools    fast    atomic    experimented    pbi    forecasted    armies    2014    sme    triage    team    uniting    founded    oral    specialist    partial    seasoned    managers    published    fto    doctors    2009    technological    instrument    business    transportable    people    requiring    exposed    staff    care    validation    usa    contact    diagnostic    irradiation    innovative    fulfil    schedule    young    international    commercialize    scientific    45    cartography    15    biological    protected    potentially    game    radiological    biodosimetry    nuclear    reached    critical    ip    lack    regulatory    minutes    french    continued    2024    communications    final    changer    trl6    medical    worldwide    competencies    publications    nrbc    prototype    exercise    accident    market    responders    undergoing    collaborations    invented    dosimetric    emergency    crisis    initial    israel    sales    booster    radiation    bio    exposure    acubens    classify    unmet    actions    device    giving    revenue    starting    commercial    dosikit    performed    individuals    patents    validated   

Project "DosiKit" data sheet

The following table provides information about the project.

Coordinator
ACUBENS 

Organization address
address: 15 RUE PIERRE GILLES DE GENNES
city: NANTERRE
postcode: 92160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACUBENS FR (NANTERRE) coordinator 50˙000.00

Map

 Project objective

Acubens was founded in 2014, to develop and commercialize new game-changer medical diagnostic devices around NRBC emergency. Our team gathers young and experimented doctors, and seasoned business managers, uniting their competencies to develop nuclear/radiological/biological innovative transportable biodosimetry devices. Nuclear/radiological accident can expose individuals to radiation, with the need for fast triage of potentially exposed people requiring immediate medical care. There is today a lack of irradiation biodosimetry tools that can be used in the field, by non-specialist staff, giving immediate results and exposure cartography in case of Partial-Body irradiation (PBI). To fulfil this critical unmet need for better initial crisis management, we invented the DosiKit device and fast test (45 minutes) to identify and classify irradiated individuals, directly in the field. This development was initiated in 2009 by the French Atomic Energy Commission within the European Commission program, BOOSTER (‘BiO-dOSimetric Tools for triagE to Responders’), and then continued by Acubens. DosiKit technology is protected by 3 international patents and has reached TRL6 with a prototype validated in a large-scale exercise performed with the French army. Several collaborations are undergoing for biological validation with French research institute and hospitals. Scientific and technical development was published in 3 scientific publications and many international oral communications. A strong contact has established with French, Germany, Israel, US and Singapore armies (LoI). This DosiKit product will be on the market in 2022, starting in Europe and then extending worldwide. Forecasted sales revenue is 15 M€ in 2024. The objectives of this phase 1 SME-Instrument are: (1) the final Biological and Technological validation of the device, (2) IP, FTO, Regulatory and risk assessment studies and (3) a market survey in Europe and USA to schedule our commercial actions.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DOSIKIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DOSIKIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

ADAPTOS (2019)

ADAPTOS - Changing the way bone voids are treated

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More